Camosunate adjudged 2012 best anti-malarial drug
In what appeared to be a landmark achievement for Geneith Pharmaceuticals Limited, Camosunate (ACT), one of the company’s leading brands, has been named 2012 best malaria management drug by the Institute for Government Research and Leadership Technology.
The award ceremony, which took place during the African Products Forum held at the Presidential Hotel in Port Harcourt on Saturday, 8th December, 2012, attracted many doctors, pharmacists and other health practitioners from Nigeria and other African countries.
Speaking at the event, Ambassador Moses Essien, head of the institute, explained why Camosunate was voted the best in the anti-malarial category.
“Before announcing Camosunate as the winner, we looked at many positive indicators, such as quality, value creation and efficacy. We also acknowledged the international standards, compliance with regulatory laws and guidelines, track record and ethical standards association,” he said.
Expressing his gratitude for the award, Emmanuel Umenwa, Chairman / CEO, Geneith Pharmaceuticals, described the achievement as a testimony to the company’s commitment to professionalism and ethical standard.
“We are honoured to be recognised here today by such a credible and prestigious organisation like Institute for Government Research and Leadership Technology. It is indeed a justification that Camosunate still remains the leading brand in anti-malarial drugs sector,” he enthused.
Malaria is a life-threatening disease caused by parasites that are transmitted to people through the bites of infected mosquitoes. According to the latest estimates, there were about 219 million cases of malaria in 2010 (with an uncertainty range of 154 million to 289 million) and an estimated 660,000 deaths (with an uncertainty range of 490 000 to 836 000).
Malaria mortality rates have fallen by more than 25% globally, since 2000, and by 33% in the WHO African Region. Most deaths occur among children living in Africa, where a child dies every minute from malaria.
Country-level burden estimates available for 2010 show that an estimated 80% of malaria deaths occur in just 14 countries and about 80% of cases occur in 17 countries.
Together, the Democratic Republic of the Congo and Nigeria account for over 40% of the estimated total of malaria deaths globally.